Lv33
310 积分 2025-06-05 加入
CD38 — a new target in renal immune disease
14天前
已完结
New insights in Type I and II CD20 antibody mechanisms‐of‐action with a panel of novel CD20 antibodies
19天前
已完结
Membranous nephropathy
21天前
已完结
Rethinking bronchiectasis as an inflammatory disease
1个月前
已完结
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
1个月前
已完结
Ensifentrine: a novel approach to redefining COPD management and implications for additional respiratory diseases
1个月前
已完结
皖公网安备34019202002308
